Novo Obesity Shot Wegovy Helped Alcoholics Drink Less in Study
Novo Nordisk A/S’s obesity shot Wegovy helped people with alcoholism reduce their drinking, in the first controlled study…
Novo Rebrands Diabetes Pill as Ozempic to Tap Blockbuster Name
Novo Nordisk A/S is rebranding an existing, less-popular diabetes tablet as Ozempic in the US in a bid…
Drugmaker Leo Pharma Is Said to Pick Banks for Copenhagen IPO
Drugmaker Leo Pharma AS has lined up investment banks to lead a potential initial public offering as soon…
Novo Nordisk, OpenAI Bring AI Into Core Operations to Accelerate Time to Market
Novo Nordisk, the maker of weight loss drugs Ozempic and Wegovy, has partnered with OpenAI to embed advanced…
Oral Weight-Loss Drug Battle: Novo Nordisk vs Eli Lilly’s New Treatments – News and Statistics
Apr 5, 2026 The competition between Novo Nordisk and Eli Lilly for dominance in the weight-loss medication sector…
Novo Nordisk’s Strategic Shift: Appointing Confectionary Executive to Boost U.S. Obesity Market Presence
Novo Nordisk has taken a significant step in bolstering its U.S. market presence by appointing Poul Weihrauch,…
Novo Nordisk’s Future in Chinese Healthcare
During a recent meeting, China’s Vice Commerce Minister, Ling Ji, encouraged Novo Nordisk to deepen its engagement…
Danske Bank Cuts 420 Jobs as Automation Reshapes Support Roles
Danske Bank A/S has eliminated 420 jobs across its regional operations, saying increased automation has reduced the need…
Novo Nordisk Navigates FDA Scrutiny with Confidence
Novo Nordisk has been issued a warning letter by the U.S. Food and Drug Administration following an…
Novo Nordisk Addresses FDA Concerns with Action Plan
Novo Nordisk, the Danish pharmaceutical giant, announced on Tuesday it had received a warning letter from the…